nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of Blood Platelets after Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Bypass Graft Surgery
|
Urszula Kralisz |
|
2000 |
10 |
3 |
p. 255-264 10 p. |
artikel |
2 |
Activation of Blood Platelets after Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Bypass Graft Surgery
|
Kralisz, Urszula |
|
2000 |
10 |
3 |
p. 255-264 |
artikel |
3 |
Argatroban and Alteplase in Patients with Acute Myocardial Infarction: The ARGAMI Study
|
Frank Vermeer |
|
2000 |
10 |
3 |
p. 233-240 8 p. |
artikel |
4 |
Argatroban and Alteplase in Patients with Acute Myocardial Infarction: The ARGAMI Study
|
Vermeer, Frank |
|
2000 |
10 |
3 |
p. 233-240 |
artikel |
5 |
Association of Endogenous Tissue Plasminogen Activator (t-PA) with Clinical Characteristics of the Insulin Resistance Syndrome
|
Lynn L. Amowitz |
|
2000 |
10 |
3 |
p. 227-231 5 p. |
artikel |
6 |
Association of Endogenous Tissue Plasminogen Activator (t-PA) with Clinical Characteristics of the Insulin Resistance Syndrome
|
Amowitz, Lynn L. |
|
2000 |
10 |
3 |
p. 227-231 |
artikel |
7 |
Impaired Culprit Vessel Flow in Acute Coronary Syndromes Ineligible for Thrombolysis
|
Peter A. McCullough |
|
2000 |
10 |
3 |
p. 247-253 7 p. |
artikel |
8 |
Impaired Culprit Vessel Flow in Acute Coronary Syndromes Ineligible for Thrombolysis
|
McCullough, Peter A. |
|
2000 |
10 |
3 |
p. 247-253 |
artikel |
9 |
Intramyocardial Injection of DNA Encoding Vascular Endothelial Growth Factor in a Myocardial Infarction Model
|
Robert A. Kloner |
|
2000 |
10 |
3 |
p. 285-289 5 p. |
artikel |
10 |
Intramyocardial Injection of DNA Encoding Vascular Endothelial Growth Factor in a Myocardial Infarction Model
|
Kloner, Robert A. |
|
2000 |
10 |
3 |
p. 285-289 |
artikel |
11 |
Left Circumflex OcclusionUnderrecognized and Undertreated
|
James H. O'Keefe Jr. |
|
2000 |
10 |
3 |
p. 221-225 5 p. |
artikel |
12 |
Left Circumflex Occlusion—Underrecognized and Undertreated
|
O'Keefe, James H. |
|
2000 |
10 |
3 |
p. 221-225 |
artikel |
13 |
Oral Platelet IIbIIIa Inhibitors: From Attractive Theory to Clinical Failures
|
Paul A. Gurbel |
|
2000 |
10 |
3 |
p. 217-220 4 p. |
artikel |
14 |
Oral Platelet IIb/IIIa Inhibitors: From Attractive Theory to Clinical Failures
|
Gurbel, Paul A. |
|
2000 |
10 |
3 |
p. 217-220 |
artikel |
15 |
Small-Molecule Glycoprotein IIbIIIa Inhibitors as Adjunctive Therapy in Percutaneous Coronary Interventions
|
J. Conor O'Shea |
|
2000 |
10 |
3 |
p. 211-215 5 p. |
artikel |
16 |
Small-Molecule Glycoprotein IIb/IIIa Inhibitors as Adjunctive Therapy in Percutaneous Coronary Interventions
|
O'Shea, J. Conor |
|
2000 |
10 |
3 |
p. 211-215 |
artikel |
17 |
The Antithrombotic Effects of CI-1028, an Orally Bioavailable Direct Thrombin Inhibitor, in a Canine Model of Venous and Arterial Thrombosis
|
Thomas B. McClanahan |
|
2000 |
10 |
3 |
p. 277-284 8 p. |
artikel |
18 |
The Antithrombotic Effects of CI-1028, an Orally Bioavailable Direct Thrombin Inhibitor, in a Canine Model of Venous and Arterial Thrombosis
|
McClanahan, Thomas B. |
|
2000 |
10 |
3 |
p. 277-284 |
artikel |
19 |
The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design
|
Marc Cohen |
|
2000 |
10 |
3 |
p. 241-246 6 p. |
artikel |
20 |
The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design
|
Cohen, Marc |
|
2000 |
10 |
3 |
p. 241-246 |
artikel |
21 |
The Treatment and Outcome of Cancer Patients with Thromboses on Central Venous Catheters
|
David A. Frank |
|
2000 |
10 |
3 |
p. 271-275 5 p. |
artikel |
22 |
The Treatment and Outcome of Cancer Patients with Thromboses on Central Venous Catheters
|
Frank, David A. |
|
2000 |
10 |
3 |
p. 271-275 |
artikel |
23 |
Ticlopidine and Aspirin Fail to Suppress the Increased Platelet Aggregability That Follows Percutaneous Coronary Interventions
|
Dionigi Fischetti |
|
2000 |
10 |
3 |
p. 265-269 5 p. |
artikel |
24 |
Ticlopidine and Aspirin Fail to Suppress the Increased Platelet Aggregability That Follows Percutaneous Coronary Interventions
|
Fischetti, Dionigi |
|
2000 |
10 |
3 |
p. 265-269 |
artikel |